Credit: Cedars-Sinai
New research led by Clive Svendsen, PhD, executive director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, marks an important first step toward achieving more personalized therapies for people with ALS and retinitis pigmentosa, debilitating conditions that currently have no known cures.